ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 42

Subclinical Oral Inflammation Is Common Across the Spectrum of Oral Findings in Rheumatoid Arthritis Patients, Whereas Porphyromonas Gingivalis Antibodies Are Primarily a Marker for Clinical Periodontitis

Sheila Arvikar1, Hatice Hasturk 2, Klemen Strle 1, Marcy Bolster 1, Deborah Collier 1, Alpdogan Kantarci 2 and Allen Steere 1, 1Massachusetts General Hospital, Boston, MA, 2Forsyth, Cambridge, MA

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: matrix metalloproteinase (MMP) and cytokines, P. Gingivalis, Periodontitis, Rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 10, 2019

Title: RA – Etiology & Pathogenesis Poster I

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Periodontitis and immune responses to periodontal pathogens such as Porphyromonas gingivalis (Pg) are associated with rheumatoid arthritis (RA) but the mechanisms underlying these connections are incompletely understood. Our goal here was to gain further insights into inflammatory responses linking periodontal and joint inflammation in RA patients.

Methods: Seventy-three subjects underwent full-mouth dental examinations, including 33 RA patients, the majority with early RA (median symptom duration 5.5 months), all meeting 2010 ACR/EULAR criteria, 20 age and gender matched healthy subjects (HS), and 20 chronic periodontitis subjects who lacked RA (non-RA CP). Thirteen inflammatory mediators and matrix metalloproteinases (MMPs) were measured in serum, saliva, gingival crevicular fluid (GCF) and synovial fluid by bead-based multiplex immunoassay. Pg DNA in subgingival plaque Pg IgG antibodies in serum and were also measured.

Results: Of the 33 RA patients, 30 (91%) received routine dental care, and only one currently smoked. However, on clinical assessment, only 10 of the 33 patients (30%) had healthy periodontium, 13 (39%) had gingivitis, a periodontitis precursor, and 10 (30%) had periodontitis.

Compared with HS and non-RA CP, RA patients had the most elevated serum levels of inflammatory mediators and MMPs, with exception of MMP-3, which was more enriched in the sera of non-RA CP patients (P< 0.005 vs. HS). In RA synovial fluid, the Th1-associated mediator, CXCL10, innate immune mediators, IL-6 and IL-8, and MMPs, particularly MMP-1 and MMP-3, were most concentrated compared with serum (P≤0.0001).

In saliva, the non-RA CP group had greatest concentration of inflammatory mediators, particularly the neutrophil chemoattractant IL-8, and elevated levels of MMPs, especially MMP-1, MMP-8, and MMP-9 (P< 0.002). In GCF, a similar inflammatory profile was observed and additionally levels of the anti-inflammatory cytokine IL-10 were significantly lower than in HS. Although values were somewhat lower, RA patients also had elevation of IL-8 in both saliva and GCF (P=0.02), and levels of MMP-8, and MMP-9 were also elevated, particularly in saliva (P< 0.002). Similar to the non-RA chronic periodontitis group, levels of IL-10 were decreased in GCF of RA patients compared with HS (P=0.005). When RA patients were stratified according to dental status (healthy, gingivitis, or periodontitis), there were no significant differences in the levels of inflammatory mediators. In contrast, Pg antibodies in serum or Pg DNA in subgingival plaque were found only in RA patients with clinical periodontitis.

Conclusion: While RA patients had systemic and joint inflammation, as expected, they also had elevated levels of periodontitis-associated mediators in oral fluids, even in the absence of clinical periodontitis. Levels of IL-8, a chemoattractant for neutrophils, the major effector cell in periodontitis, and MMPs were particularly elevated. Thus, the oral mucosa may be a common, but often unrecognized, site of extra-articular inflammation in RA. In contrast, Pg antibodies and DNA seem to be a marker only for frank periodontitis.


Disclosure: S. Arvikar, None; H. Hasturk, None; K. Strle, None; M. Bolster, Abbvie, 2, Corbus, 9, Cumberland, 9, Gilead, 5, Johnson & Johnson, 4, Johnson and Johnson, 4, Pfizer, 2; D. Collier, None; A. Kantarci, None; A. Steere, None.

To cite this abstract in AMA style:

Arvikar S, Hasturk H, Strle K, Bolster M, Collier D, Kantarci A, Steere A. Subclinical Oral Inflammation Is Common Across the Spectrum of Oral Findings in Rheumatoid Arthritis Patients, Whereas Porphyromonas Gingivalis Antibodies Are Primarily a Marker for Clinical Periodontitis [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/subclinical-oral-inflammation-is-common-across-the-spectrum-of-oral-findings-in-rheumatoid-arthritis-patients-whereas-porphyromonas-gingivalis-antibodies-are-primarily-a-marker-for-clinical-periodont/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/subclinical-oral-inflammation-is-common-across-the-spectrum-of-oral-findings-in-rheumatoid-arthritis-patients-whereas-porphyromonas-gingivalis-antibodies-are-primarily-a-marker-for-clinical-periodont/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology